1. Home
  2. PSTV vs SPCB Comparison

PSTV vs SPCB Comparison

Compare PSTV & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • SPCB
  • Stock Information
  • Founded
  • PSTV 1996
  • SPCB 1988
  • Country
  • PSTV United States
  • SPCB Israel
  • Employees
  • PSTV N/A
  • SPCB N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • SPCB Semiconductors
  • Sector
  • PSTV Health Care
  • SPCB Technology
  • Exchange
  • PSTV Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • PSTV 6.3M
  • SPCB 6.4M
  • IPO Year
  • PSTV N/A
  • SPCB N/A
  • Fundamental
  • Price
  • PSTV $1.07
  • SPCB $3.40
  • Analyst Decision
  • PSTV Strong Buy
  • SPCB
  • Analyst Count
  • PSTV 2
  • SPCB 0
  • Target Price
  • PSTV $13.50
  • SPCB N/A
  • AVG Volume (30 Days)
  • PSTV 90.1K
  • SPCB 81.3K
  • Earning Date
  • PSTV 11-14-2024
  • SPCB 11-14-2024
  • Dividend Yield
  • PSTV N/A
  • SPCB N/A
  • EPS Growth
  • PSTV N/A
  • SPCB N/A
  • EPS
  • PSTV N/A
  • SPCB 1.02
  • Revenue
  • PSTV $5,725,000.00
  • SPCB $26,843,000.00
  • Revenue This Year
  • PSTV $32.12
  • SPCB $6.72
  • Revenue Next Year
  • PSTV N/A
  • SPCB $15.83
  • P/E Ratio
  • PSTV N/A
  • SPCB $3.32
  • Revenue Growth
  • PSTV 52.63
  • SPCB 5.23
  • 52 Week Low
  • PSTV $0.93
  • SPCB $2.55
  • 52 Week High
  • PSTV $2.67
  • SPCB $11.00
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 31.28
  • SPCB 47.43
  • Support Level
  • PSTV $0.93
  • SPCB $3.14
  • Resistance Level
  • PSTV $1.37
  • SPCB $3.68
  • Average True Range (ATR)
  • PSTV 0.11
  • SPCB 0.22
  • MACD
  • PSTV -0.04
  • SPCB 0.01
  • Stochastic Oscillator
  • PSTV 15.87
  • SPCB 43.33

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

Share on Social Networks: